Overview
- The walkout, which entered a fifth day Tuesday, involves about 2,800 of the union’s 4,000 members and will shift to a work-to-rule campaign after the five-day strike.
- Government-mediated talks restarted Monday without a breakthrough, and both sides plan two more meetings later this week.
- The union seeks a 14% raise in base and performance pay, a 30 million won cash payout per worker, and bonuses equal to 20% of annual operating profit, while the company offers a combined 6.2% pay increase.
- Samsung Biologics reports about 150 billion won in losses from earlier partial stoppages and estimates a five-day full strike could cost around 640 billion won.
- Partial process halts have disrupted steps like aliquoting and affected output of cancer and HIV treatments, raising delivery risks for a contract manufacturer whose edge is stable, on-time production.